Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis

International Journal of Gynecology and Obstetrics

Volumn 113, Issue 2, 2011, Pages 156-157

  Karaosmanoglu, Ozge ^a   Cogendez, Ebru ^b   Sozen, Hamdullah ^b   Asoglu, Mehmet R ^b   Akdemir, Yesim ^b   Eren, Sadiye ^b  

^a Merzifon Public Hospital Amasya   (Turkey)

^b Neonatal Intensive Care Unit   (Turkey)

Author keywords

Atrophic vaginitis; Hyaluronic acid; Vaginal wall biopsy

Indexed keywords

CICATRIDINA; HYALURONIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME; VAGINA; VAGINA ATROPHY;

EID: 79953777566     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.12.007     Document Type: Article

References (4)

1. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362(9382):419-27.
2. Ekin M, Yaşar L, Savan K, Temur M, Uhri M, Gencer I, et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet 2011(283):539-43.
3. Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marrè GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung 2006;56(3):230-8.
4. Uzuka M, Nakajima K, Ohta S, Mori Y. Induction of hyaluronic acid synthetase by estrogen in the mouse skin. Biochim Biophys Acta 1981;673(4):387-93. (Pubitemid 11103740)